Michael Pollan - On legalisation of psilocybin

Psilocybin legalization and the broader political strategy for psychedelic liberalization are contested by Michael Pollan, who warns against conflating this movement with the legalization of cannabis. Unlike the cannabis model, which successfully addressed the severe injustices of the US drug war, psilocybin remains in a promising, non-political phase of FDA approval as a medicine. Pollan argues that rushing toward full legalization before establishing an appropriate regulatory framework poses distinct risks, particularly regarding corporate influence and the nature of these profound psychological experiences. Instead of broad commercialization, he emphasizes the need to develop safe, controlled containers for psychedelic use, similar to current guided therapeutic models or specific religious practices. He advocates for a cautious approach that prioritizes these structured settings to ensure safety, urging the community to determine the proper social, medical, and ethical containment for these powerful substances before advocating for widespread availability.